Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy
Jeremy M. Kelm, Deepti S. Pandey, Evan Malin, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Exploring the next generation of antibody–drug conjugates
Kyoji Tsuchikama, Yasuaki Anami, Summer Y. Y. Ha, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 203-223
Open Access | Times Cited: 172
Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112
BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy
Shiman Lu, Zhaoqing Shi, Chendi Ding, et al.
Biomaterials (2025) Vol. 317, pp. 123101-123101
Closed Access | Times Cited: 2
Navigating the ERK1/2 MAPK Cascade
Ana Martín-Vega, Melanie H. Cobb
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1555-1555
Open Access | Times Cited: 35
Proactive and reactive roles of TGF-β in cancer
Nick A. Kuburich, Thiru Sabapathy, Breanna R. Demestichas, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 120-139
Open Access | Times Cited: 22
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Youyi Huang, Xiaofang Che, Peter Wang, et al.
Seminars in Cancer Biology (2024) Vol. 101, pp. 44-57
Closed Access | Times Cited: 11
Progress in the development of Macrophage Migration Inhibitory Factor small-molecule inhibitors
Shujin Guo, Yingying Zhao, Yan Yuan, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117280-117280
Closed Access | Times Cited: 1
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
Small Molecule Drugs Targeting Viral Polymerases
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 661-661
Open Access | Times Cited: 7
The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov, Hyunbum Jang
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1071-1085
Open Access | Times Cited: 7
PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
Xiaohui Ren, Lijuan Wang, Likun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Molecular glues targeting GSPT1 in cancers: A potent therapy
Dandan Zhang, Pei Lin, Jun Lin
Bioorganic Chemistry (2023) Vol. 143, pp. 107000-107000
Closed Access | Times Cited: 13
Ailanthone induces triple-negative breast cancer cells death involving the inhibition of OTUB1-mediated ERRα deubiquitylation
Ziyue Zhang, Wei Huang, Li Wang, et al.
Journal of Advanced Research (2025)
Open Access
Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections
Riming Huang, Yusi Hu, Yifan Wang, et al.
Angewandte Chemie International Edition (2025)
Closed Access
Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections
Riming Huang, Yusi Hu, Yifan Wang, et al.
Angewandte Chemie (2025)
Closed Access
Progress in ubiquitination and hepatocellular carcinoma: a bibliometric analysis
Ming Li, Zhiliang Xu, Shanhui Liang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Targeted degradation of CDK9 potently disrupts the MYC-regulated network
Mohammed A. Toure, Keisuke Motoyama, Yichen Xiang, et al.
Cell chemical biology (2025)
Open Access
Target protein degradation by protacs: A budding cancer treatment strategy
Diksha Choudhary, Amritpal Kaur, Pargat Singh, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108525-108525
Closed Access | Times Cited: 12
Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors
Haiting Duan, Jingyu Zhang, Renzhao Gui, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11326-11353
Closed Access | Times Cited: 4
EGFR molecular degraders: preclinical successes and the road ahead
Naveen Chand Rallabandi, Dayanand Panpatil, Digvijay Gahtory, et al.
Future Medicinal Chemistry (2025), pp. 1-4
Closed Access
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors
Eloïne Bestion, Éric Raymond, Soraya Mezouar, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1702-1702
Open Access | Times Cited: 10
PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis
Minxing Shi, Xi Ding, Liang Tang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy
Yazhen Wang, Lianyi Yang, C. Yan, et al.
Science Advances (2024) Vol. 10, Iss. 25
Open Access | Times Cited: 3
Advances in designing ternary complexes: Integrating in-silico and biochemical methods for PROTAC optimisation in target protein degradation
Shareef Shaik, Prasanna Kumar Reddy Gayam, Manish Chaudhary, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107868-107868
Open Access | Times Cited: 3
Construction of PROTAC-Mediated Ternary Complex Structure Distribution Profiles Using Extensive Conformational Search
Genki Kudo, Takumi Hirao, Ryuhei Harada, et al.
(2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top